Researchers from the Indiana University Center for Aging Research and the Regenstrief Institute have performed the first study conducted in the United States under real-world conditions comparing patient adherence and tolerability to a class of drugs known as cholinesterase inhibitors. Although there are no known cures for Alzheimer’s disease or other dementias, drugs in this class may delay or slow the progression of symptoms in some individuals.
from Dementia Big http://ift.tt/2nBfiQk via alcoholic dementia
http://ift.tt/2opypf7
No comments:
Post a Comment